Patients Coming Off Slimming Medications Regain Weight at a Quadrupled Rate Than Dieters

Fresh analysis reveals that people who come off new GLP-1 drugs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who end traditional diet and exercise plans.

Published data in a prominent medical journal demonstrates that while overweight individuals can lose a large proportion of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"People purchasing such drugs must be cognizant of the potential of fast rebound weight gain when the treatment ends," cautioned researcher Dr. Susan Jebb.

This pace of recovery means a reversion to original mass in about 18 months.

Analyzing Therapies

The study, which examined 37 of studies involving thousands of patients, contrasted the effects of the injectable medications with older methods.

The team point out that individuals who shed pounds through diet and exercise typically experience a slower weight regain—approximately 0.1 kg a month—post-intervention.

The Reason for the Rapid Rebound

Doctors believe the mechanism of the jabs accounts for the amplified rebound.

GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate hunger.

"Artificially providing GLP-1 levels far above than normal could lead to the body to generate a reduced amount of its endogenous hormone, and may also reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication means appetite is no longer kept in check, making overeating a significant risk."

A Chronic Issue?

Medical guidelines recommend the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Many experts contend that, given the high risk of relapse, the treatment should be considered ongoing.

This opinion is echoed by drug manufacturers, who state that the results "emphasize the persistent character of excess weight," comparing it to managing diseases like high blood pressure.

User Testimonies

Individuals who have come off the medication describe a powerful resurgence of appetite.

"I experienced a switch activating and you become ravenous," described an individual.

This difficulty is exacerbated if users have not adopted sustainable lifestyle or habit changes during treatment.

Significant Use

Recent estimates suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand being substantial.

• Adoption is more common among women than males.
• The middle-aged demographic shows the greatest level of interest.
• Many access the drugs through private prescriptions rather than the NHS.

In conclusion, experts caution that while GLP-1 drugs are potent agents for weight loss, they are not a magic fix and long-term success relies on ongoing behavioural management.